INVIVO THERAPEUTICS HOLDINGS CORP.·4

Mar 22, 9:33 PM ET

Toselli Richard M. 4

4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Mar 22, 2021

Insider Transaction Report

Form 4
Period: 2021-03-18
Toselli Richard M.
Chief Medical Officer
Transactions
  • Award

    Stock option (right to buy)

    2021-03-18+150,000150,000 total
    Exercise: $1.10Exp: 2031-03-17Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]This option was granted on March 18, 2021. The shares underlying the option vest over two years, with 50% of the shares vesting on March 18, 2022 and the remaining shares vesting on March 18, 2023.

Documents

2 files